BCL2 and acute myeloid leukemia: For example, the depletion of METTL3 in acute myeloid leukemia (AML) cells induced cell differentiation and apoptosis through METTL3-mediated m6A modification on MYC, BCL2 and PTEN mRNA, thus delaying AML progression [37].